Copyright
©The Author(s) 2018.
World J Gastroenterol. Jun 7, 2018; 24(21): 2211-2235
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2211
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2211
Diagnostic criteria for irritable bowel syndrome (IBS)[18] |
Must include all of the following |
Abdominal pain at least 4 d per month associated with one or more of the following: |
Related to defecation |
A change in frequency of stool |
A change in form (appearance) of stool |
In children with constipation, the pain does not resolve with resolution of the constipation (children in whom the pain resolves have functional constipation, not irritable bowel syndrome) |
After appropriate evaluation, the symptoms cannot be fully explained by another medical condition |
Above criteria needs to be fulfilled for at least 2 mo before diagnosis. |
Diagnostic criteria for IBS subtypes[31] |
IBS with predominant constipation |
More than one-fourth (25%) of bowel movements with Bristol stool form types 1 or 2 and less than one fourth (25%) lf bowel movements with Bristol stool form types 6 or 7 |
IBS with predominant diarrhea |
More than one-fourth (25%) of bowel movements with Bristol stool form types 6 or 7 and less than one fourth (25%) lf bowel movements with Bristol stool form types 1 or 2 |
IBS with mixed bowel habits |
More than one-fourth (25%) of bowel movements with Bristol stool form types 1 or 2 and more than one fourth (25%) lf bowel movements with Bristol stool form types 6 or 7 |
IBS unclassified |
Patients who meet diagnostic criteria for IBS but whose bowel habits cannot be accurately categorized into 1 of the 3 groups above |
Family history of inflammatory bowel disease, celiac disease or peptic ulcer disease |
Persistent right upper or lower abdominal pain |
Dysphagia |
Odynophagia |
Persistent vomiting |
Gastrointestinal blood loss |
Nocturnal diarrhea |
Arthritis |
Perirectal disease |
Involuntary weight loss |
Deceleration of linear growth |
Delayed puberty |
Unexplained fever |
Counselling and explanation to parents/child |
Control maternal response to child’s pain |
Pharmacological interventions |
Gastroprokinetics (domperidone) |
Antidepressants (amitriptyline, citalopram) |
Acid suppressing agents (famotidine, omeprazole) |
Antispasmodics (peppermint oil, mebavarine, dotavarine) |
Antihistamines (cyproheptadine) |
Antibiotics (rifaximin) |
Psychological interventions |
Guided imagery |
Gut directed hypnotherapy |
Cognitive behavioral therapy |
Yoga therapy |
Neuromodulation |
Low FODMAP diet |
Probiotics |
- Citation: Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol 2018; 24(21): 2211-2235
- URL: https://www.wjgnet.com/1007-9327/full/v24/i21/2211.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i21.2211